CULTURE REVIEW SERVICE
When starting an outpatient stewardship program, a culture review service is an efficacious way to make a positive impact on patient care. Additionally, this service allows providers to interact with members of the stewardship program. A culture review service follows up on cultures taken in various settings, such as the ED and primary care clinics, and makes interventions to optimize therapy. Findings from one study estimated that interventions are made in approximately 20% of cases.3 Results from this study also found that pharmacist intervention decreased the rates of 30-day treatment failure and 30-day admission. Review of antibiotic orders was estimated to take as little as 5 minutes and up to 30 minutes for some orders with associated cultures that required intervention. Given the minimal time commitment and the significant improvements in patient outcomes, a culture review service is an excellent return on investment. Culture review services are also an excellent way to close the gap between various levels of care in the outpatient setting. These services allow the stewardship team to establish themselves as the experts in antibiotic therapy while collaborating with other members of the health care professional team before expanding the service to further eliminate inappropriate antimicrobial use.
AUDIT AND FEEDBACK
Dashboards can be used to compare antibiotics for specific disease states and various sites and providers. This information can be used for comparison and positive reinforcement to providers. Similarly, academic detailing can be used to start focused discussions with prescribers to try to reduce the overprescribing of antibiotics. The educator must take the time to understand the reasons for overprescribing antibiotics. These can include lack of understanding, inadequate time to review guideline updates, fear of missing bacterial infections, or patient satisfaction. The conversation can then be molded into specific practice-changing recommendations.17
FLUOROQUINOLONE RESTRICTION
Over the years, the US Food and Drug Administration (FDA) has published numerous warnings for fluoroquinolones. These warnings include tendonitis, tendon rupture, aortic dissection or rupture, peripheral neuropathy, exacerbation of myasthenia gravis, disturbances in blood glucose levels, and central nervous system effects. Given the potential for harm and the overuse associated with these agents, it’s a reasonable intervention to target when setting up a stewardship program. One study used a multimodal initiative to curb fluoroquinolone use.18 The infectious diseases pharmacist educated providers about the risks and appropriate use of fluoroquinolones, whereas FDA warnings were added to all fluoroquinolone orders as part of the electronic medical record concomitantly. Furthermore, fluoroquinolone susceptibilities were suppressed if the microorganism was susceptible to a third-generation cephalosporin. Lastly, order sets were made to guide prescribing away from fluoroquinolones. As a result, fluoroquinolone usage dropped by 39%.
CONCLUSIONS
Outpatient antimicrobial stewardship programs improve patient care by optimizing antibiotic use. Results from studies have shown that outpatient stewardship programs, especially those that perform culture reviews, can decrease rates of treatment failure, hospital admissions, and health care costs. Various methods can be employed by outpatient antimicrobial stewardship programs to improve patient care. Targeting specific indications that are frequently associated with overuse and targeting specific patient populations can help minimize unnecessary use. Optimizing dosing can help to improve efficacy and reduce toxicity. Furthermore, limiting durations of therapy, in accordance with guidelines, can help minimize risk of potential antibiotic-related adverse drug reactions. Developing a culture review service, restricting certain antibiotics or antibiotic classes, providing prospective audit and feedback, and implementing dashboards are all methods to help establish a successful stewardship program.
References
1.CDC. Measuring Outpatient Antibiotic Prescribing. Accessed 8/10/2023, https://www.cdc.gov/antibiotic-use/data/outpatient-prescribing/index.html#f10
2.White AT, Clark CM, Sellick JA, Mergenhagen KA. Antibiotic stewardship targets in the outpatient setting. Am J Infect Control. Aug 2019;47(8):858-863. doi:10.1016/j.ajic.2019.01.027
3.Wattengel BA, Sellick JA, Mergenhagen KA. Outpatient antimicrobial stewardship: Optimizing patient care via pharmacist led microbiology review. Am J Infect Control. Feb 2020;48(2):189-193. doi:10.1016/j.ajic.2019.07.018
4.The White House. National Action Plan for Combating Antibiotic-Resistant Bacteria Accessed 8/11/2023, 2023. https://www.cdc.gov/drugresistance/pdf/national_action_plan_for_combating_antibotic-resistant_bacteria.pdf
5.Federal Task Force on Combating Antibiotic-Resistant Bacteria. National Action Plan for Combating Antibiotic-Resistant Bacteria. 8/11/2023, 2023. Accessed 8/11/2023, 2023. https://www.hhs.gov/sites/default/files/carb-national-action-plan-2020-2025.pdfUS
6.Kiel A, Catalano A, Clark CM, et al. Antibiotic prescribing in the emergency department versus primary care: Implications for stewardship. Journal of the American Pharmacists Association : JAPhA. Nov-Dec 2020;60(6):789-795.e2. doi:10.1016/j.japh.2020.03.016
7.Mostov PD. Treating the immunocompetent patient who presents with an upper respiratory infection: pharyngitis, sinusitis, and bronchitis. Prim Care. Mar 2007;34(1):39-58. doi:10.1016/j.pop.2006.09.009
8.Wattengel BA, Sellick JA, Skelly MK, Napierala R, Jr., Schroeck J, Mergenhagen KA. Outpatient Antimicrobial Stewardship: Targets for Community-Acquired Pneumonia. Clinical therapeutics. Feb 7 2019;doi:10.1016/j.clinthera.2019.01.007
9.Wattengel BA, DiTursi S, Schroeck JL, Sellick JA, Mergenhagen KA. Outpatient antimicrobial stewardship: Targets for urinary tract infections. American journal of infection control. Sep 2020;48(9):1009-1012. doi:10.1016/j.ajic.2019.12.018
10.Amenta EM, Jump RLP, Trautner BW. Bacteriuria in older adults triggers confusion in healthcare providers: A mindful pause to treat the worry. Antimicrobial stewardship & healthcare epidemiology : ASHE. 2023;3(1):e4. doi:10.1017/ash.2022.343
11.Krouss M, Alaiev D, Shin DW, et al. Choosing wisely initiative for reducing urine cultures for asymptomatic bacteriuria and catheter-associated asymptomatic bacteriuria in an 11-hospital safety net system. Am J Infect Control. Apr 2023;51(4):461-465. doi:10.1016/j.ajic.2023.01.005
12.Claeys KC, Trautner BW, Leekha S, et al. Optimal Urine Culture Diagnostic Stewardship Practice-Results from an Expert Modified-Delphi Procedure. Clin Infect Dis. Aug 31 2022;75(3):382-389. doi:10.1093/cid/ciab987
13.Cheng B, Zaman M, Cox W. Correlation of Pyuria and Bacteriuria in Acute Care. Am J Med. Sep 2022;135(9):e353-e358. doi:10.1016/j.amjmed.2022.04.022
14.Cortes-Penfield NW, Trautner BW, Jump RLP. Urinary Tract Infection and Asymptomatic Bacteriuria in Older Adults. Infect Dis Clin North Am. Dec 2017;31(4):673-688. doi:10.1016/j.idc.2017.07.002
15.Gerber JS, Prasad PA, Fiks AG, et al. Durability of benefits of an outpatient antimicrobial stewardship intervention after discontinuation of audit and feedback. JAMA. Dec 17 2014;312(23):2569-70. doi:10.1001/jama.2014.14042
16.Nicolle LE, Gupta K, Bradley SF, et al. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. May 2 2019;68(10):e83-e110. doi:10.1093/cid/ciy1121
17.Dobson EL, Klepser ME, Pogue JM, et al. Outpatient antibiotic stewardship: Interventions and opportunities. Journal of the American Pharmacists Association : JAPhA. Jul-Aug 2017;57(4):464-473. doi:10.1016/j.japh.2017.03.014
18.Lin K, Zahlanie Y, Ortwine JK, et al. Decreased Outpatient Fluoroquinolone Prescribing Using a Multimodal Antimicrobial Stewardship Initiative. Open Forum Infect Dis. Jun 2020;7(6):ofaa182. doi:10.1093/ofid/ofaa182